These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9857876)

  • 1. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy.
    Yetman AT; Hamilton RM; Benson LN; McCrindle BW
    J Am Coll Cardiol; 1998 Dec; 32(7):1943-50. PubMed ID: 9857876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease.
    Mohiddin SA; Begley D; Shih J; Fananapazir L
    J Am Coll Cardiol; 2000 Dec; 36(7):2270-8. PubMed ID: 11127472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is QT dispersion associated with sudden cardiac death in patients with hypertrophic cardiomyopathy?
    Yi G; Poloniecki J; Dickie S; Elliott PM; Malik M; McKenna WJ
    Ann Noninvasive Electrocardiol; 2001 Jul; 6(3):209-15. PubMed ID: 11466139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death.
    Yetman AT; McCrindle BW; MacDonald C; Freedom RM; Gow R
    N Engl J Med; 1998 Oct; 339(17):1201-9. PubMed ID: 9780340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of time and frequency domain, and spectral temporal mapping analysis of the signal-averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death.
    Kulakowski P; Counihan PJ; Camm AJ; McKenna WJ
    Eur Heart J; 1993 Jul; 14(7):941-50. PubMed ID: 8375420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial bridging in adult patients with hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Nishimura RA; Gersh BJ; Tajik AJ; Holmes DR
    J Am Coll Cardiol; 2003 Sep; 42(5):889-94. PubMed ID: 12957438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly.
    Ostman-Smith I; Wettrell G; Keeton B; Riesenfeld T; Holmgren D; Ergander U
    Cardiol Young; 2005 Dec; 15(6):632-42. PubMed ID: 16297259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients.
    El-Saiedi SA; Seliem ZS; Esmail RI
    Cardiol Young; 2014 Aug; 24(4):702-8. PubMed ID: 23895893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
    Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
    J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.
    Fananapazir L; Chang AC; Epstein SE; McAreavey D
    Circulation; 1992 Sep; 86(3):730-40. PubMed ID: 1516184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement.
    Limongelli G; Masarone D; Frisso G; Iacomino M; Ferrara I; Rea A; Gravino R; Bossone E; Salvatore F; Calabro R; Elliott P; Pacileo G
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):249-254. PubMed ID: 26808413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
    Rowin EJ; Maron BJ; Haas TS; Garberich RF; Wang W; Link MS; Maron MS
    J Am Coll Cardiol; 2017 Feb; 69(7):761-773. PubMed ID: 28209216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
    Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
    Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.